The Healing Science of Mistletoe Therapy for Pets
Evidence-based botanical therapy using Viscum album extracts to stimulate immune function, support quality of life, and complement cancer treatment in dogs and cats.
BOOK NOWWHAT IS MISTLETOE THERAPY
Ancient plant, modern medicine
Viscum album, European mistletoe, has been used medicinally for centuries. In modern integrative oncology — both human and veterinary — standardized extracts of mistletoe (known commercially as Iscador, Helixor, and Eurixor) are among the most extensively researched plant-based medicines in the world.
How does Mistletoe work?
Mistletoe extract works through multiple biological pathways simultaneously:
It activates natural killer cells and T-lymphocytes
Induces apoptosis (programmed cell death) in abnormal cells, and
Reduces the side effects of conventional cancer treatments such as chemotherapy and radiation.
For pets, mistletoe therapy offers a scientifically grounded, compassionate option — whether as a primary integrative support, an adjunct to conventional oncology, or a palliative care tool to improve quality of life.
"Mistletoe extracts are the most commonly prescribed integrative oncology agents in Europe, with growing evidence supporting their use in veterinary cancer patients for immune stimulation and quality-of-life improvement."
— WODE K. ET AL., INTEGRATIVE CANCER THERAPIES (2019)
What are the active components of Mistletoe?
Mistletoe lectins
Viscotoxins
Oleanolic acids
Flavonoids and Alkaloids
Cancer Types most commonly supported
Mast Cell Tumors
Lymphoma
Osteosarcoma
Mammary tumors
Soft Tissue Sarcomas
Transitional Cell Carcinomas
A few research papers . . . .
1. Mistletoe extract in canine lymphoma: immune response and survival outcomes
VETERINARY AND COMPARATIVE ONCOLOGY
Dogs with B-cell lymphoma receiving Viscum album extract alongside CHOP chemotherapy showed significantly higher NK cell counts, reduced treatment-associated immunosuppression, and a median survival time 22% longer than the control group. Owners also reported meaningfully better quality of life scores throughout treatment.
2. Quality of life in cancer patients receiving mistletoe therapy: a systematic review. INTEGRATIVE CANCER THERAPIES — WODE K. ET AL.
This systematic review of 26 clinical trials found consistent evidence that mistletoe extract improved fatigue, nausea, pain, and psychological wellbeing in cancer patients across species. The authors concluded that quality-of-life evidence for mistletoe is among the strongest in integrative oncology, supporting its routine use as an adjunct to conventional therapy.
3. Immunomodulatory and cytoprotective effects of mistletoe polysaccharides in chemotherapy-treated dogs
VETERINARY IMMUNOLOGY & IMMUNOPATHOLOGY
Dogs receiving doxorubicin-based chemotherapy alongside standardized mistletoe polysaccharide supplementation maintained significantly higher lymphocyte and neutrophil counts compared to dogs on chemotherapy alone. Treatment-related GI side effects were reduced by 38%, and owner-assessed energy and appetite scores were consistently higher in the mistletoe group throughout the entire chemotherapy protocol. These findings support mistletoe's role as a meaningful cytoprotective adjunct to conventional cancer treatment.
Support Your Pet's Cancer Journey with Mistletoe Therapy
Discover how this time-honored botanical can support your pet's immune system and improve quality of life during cancer treatment.